Vir Biotechnology Inc (VIR) — Cash Flow Reinvestment Rate
Vir Biotechnology Inc (VIR) has a Cash Flow Reinvestment Rate of 4.72x as of December 2022, reinvesting $165.73 Million (capex $12.60 Million plus investments $-153.13 Million) from operating cash flow of $35.13 Million. See VIR free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Vir Biotechnology Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Vir Biotechnology Inc across 1 annual periods. For the full cash flow conversion analysis, see Vir Biotechnology Inc operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Vir Biotechnology Inc (2022–2022)
Year-by-year capital reinvestment analysis for Vir Biotechnology Inc. See Vir Biotechnology Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.76x | $1.26 Billion | $1.66 Billion | $68.01 Million | — |